眼氨肽
Records for this ingredient, by country (identity only).
ATC S01XA · 1 markets · 26 records
CN 26 records · 7 shown of 7
- 2,000 mg/2 mLinjectionManufacturer: 南京新百药业有限公司 ×2Manufacturer: 天津生物化学制药有限公司、Manufacturer: 杭州国光药业股份有限公司、Manufacturer: 陕西博森生物制药股份集团有限公司
- 1,000 mg/1 mLinjectionManufacturer: 北京赛升药业股份有限公司 ×2Manufacturer: 天津生物化学制药有限公司、Manufacturer: 湖北威仕生物药业股份有限公司
- 10 mL per mL / per unit basis not statedliquidManufacturer: 陕西博森生物制药股份集团有限公司 ×4
- 4 mL per mL / per unit basis not statedliquidManufacturer: 江苏普华克胜药业有限公司 ×5
- 5,000 mg/2 mLinjectionManufacturer: 江苏恒新药业有限公司 ×3
- 2,500 mg/1 mLinjectionManufacturer: 江苏恒新药业有限公司 ×3
- 12,500 mg/5 mLliquid叶里清眼氨肽Manufacturer: 江苏恒新药业有限公司、Manufacturer: 江苏普华克胜药业有限公司、Manufacturer: 陕西博森生物制药股份集团有限公司
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.